The affection of lipoprotein-a by lipid lowering drugs.
D001161:Arteriosclerosis / Q000097:blood; D001629:Bezafibrate / Q000494:pharmacology; D002792:Cholestyramine Resin / Q000494:pharmacology; D006728:Hormones / Q000502:physiology; D006801:Humans; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D017270:Lipoprotein(a); D008074:Lipoproteins / Q000378:metabolism*; D009355:Neomycin / Q000494:pharmacology; D009525:Niacin / Q000494:pharmacology; D009539:Nicotinic Acids / Q000494:pharmacology; D013197:Stanozolol / Q000494:pharmacology
D006728:Hormones; D000960:Hypolipidemic Agents; D017270:Lipoprotein(a); D008074:Lipoproteins; D009539:Nicotinic Acids; D002792:Cholestyramine Resin; D009525:Niacin; D013197:Stanozolol; D009355:Neomycin; D001629:Bezafibrate